Cipla Ltd launches copy of GSK’s top asthma drug in Germany, Sweden – Economic Times


Economic Times

Cipla Ltd launches copy of GSK's top asthma drug in Germany, Sweden
Economic Times
MUMBAI: Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product. Cipla's drug will be marketed under

View full post on asthma – Google News

India’s Cipla launches copy of GSK’s top asthma drug in Germany, Sweden – Reuters


Economic Times

India's Cipla launches copy of GSK's top asthma drug in Germany, Sweden
Reuters
MUMBAI (Reuters) – India's Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product. Cipla's drug will
Cipla targets US with asthma, HIV drugsMoneyweb.co.za

all 22 news articles »

View full post on asthma – Google News

India’s Cipla Launches Copy Of GSK’s Top Asthma Drug In Germany, Sweden – Business Insider


Economic Times

India's Cipla Launches Copy Of GSK's Top Asthma Drug In Germany, Sweden
Business Insider
MUMBAI (Reuters) – India's Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product. Cipla's drug will
Cipla launches Serroflo in Germany and Sweden with affordable high quality pharmabiz.com

all 6 news articles »

View full post on asthma – Google News

SkyePharma launches asthma treatment in Germany – Stock Market Wire

SkyePharma launches asthma treatment in Germany
Stock Market Wire
flutiform® was approved for the treatment of asthma maintenance therapy in Germany by its regulatory authority, Bundesinstitut für Arzneimittel und Medizinprodukte (BfARM), in July. Following the launch offlutiform® in Germany, a milestone of €4.0m is
SkyePharma Launches Flutiform In Germany – Quick FactsNASDAQ

all 4 news articles »

View full post on asthma – Google News

Asthma Fears Prompt Infant Swimming Warning in Germany – Aquatics International


Aquatics International

Asthma Fears Prompt Infant Swimming Warning in Germany
Aquatics International
Agency officials are hoping to eventually get more information on whether or not lung damage is actually done in early childhood and the extent to which it might lead to asthma. “Trichloramine (TCA) is a strong irritant, with biochemical data as well

View full post on asthma – Google News

[Stocked medications in emergency physician-based medical services in Germany : Reality and requirements according to guidelines.]

Related Articles

[Stocked medications in emergency physician-based medical services in Germany : Reality and requirements according to guidelines.]

Anaesthesist. 2010 Dec 4;

Authors: Rörtgen D, Schaumberg A, Skorning M, Bergrath S, Beckers SK, Coburn M, Brokmann JC, Fischermann H, Nieveler M, Rossaint R

BACKGROUND: The emergency medical service (EMS) should work according to criteria of evidence-based medicine. In Germany the EMS of each state is under the control of at least one medical supervisor known as emergency medical directors (EMD) and most states have several different EMDs responsible for one or more provinces of the state. The German Medical Association advises these supervisors to specify the pharmacological resources in store for use in physician powered EMSs. This study examines the pharmacological resources in EMSs which is provided by the EMDs in Germany. Furthermore, a comparison of the inventory analysis of stored drugs was carried out with the requirements according to guidelines for selected tracer diagnoses. METHOD: In the period of May 2008 to January 2009 a total of 148 EMDs were contacted and asked to supply drug storage lists for emergency physician-staffed rescue vehicles in their respective jurisdiction. The addresses of all EMDs who could be identified by the federal office of the National Association of Emergency Medical Director, Germany were used over the period. The evaluation was conducted anonymously. The tracer diagnoses “cardiopulmonary resuscitation”, “acute coronary syndrome”, “status generalized tonic-clonic seizure,” “severe asthma attack”, “acute exacerbation of chronic obstructive pulmonary disease”, “supraventricular tachycardia”, “severe brain trauma” and “acute heart failure with signs of hypoperfusion” were selected. Current and established guidelines have been identified with the homepage of the Scientific Medical Societies in Germany and supported by the leading European and International guidelines. RESULTS: The corresponding lists were returned by 95 different emergency service areas (response rate 64.2%). With a total of 39 groups of substances 142 different drugs could be identified, an average of 54±9.6 and median 55 (range 31-77). Listed are agents giving the provision in percent, for which the comparison with guidelines for tracer diagnoses could show deficits: sodium bicarbonate 75.8%, calcium 50.5%, magnesium 45.3%, noradrenaline 65.3%, adenosine 58.9%, dobutamine 57.9%, lorazepam iv 13.7%, salbutamol 41.1%, ipratropium bromide 13.7% (the last two as liquid preparations for inhalation). With a frequency of about 30-80%, depending on the respective tracer diagnosis, no medical emergency treatment according to the highest level of evidence is possible. CONCLUSION: Due to recent treatment recommendations provision with sodium bicarbonate, calcium, magnesium, noradrenaline, adenosine, lorazepam iv, dobutamine and as well with ipratropium bromide and salbutamol (both as liquid preparations for inhalation) should be improved. For the future, a federal uniform minimum standard due to evidence-based principles is desirable.

PMID: 21127828 [PubMed – as supplied by publisher]

View full post on pubmed: asthma